Acute Kidney Injury in Traumatic Brain Injury Patients: Results From the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study

Chiara Robba, Erika Banzato, Paola Rebora, Carolina Iaquaniello, Chao-Yuan Huang, Eveline J A Wiegers, Geert Meyfroidt, Giuseppe Citerio, Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) ICU Participants and Investigators, Chiara Robba, Erika Banzato, Paola Rebora, Carolina Iaquaniello, Chao-Yuan Huang, Eveline J A Wiegers, Geert Meyfroidt, Giuseppe Citerio, Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) ICU Participants and Investigators

Abstract

Objectives: Acute kidney injury is frequent in polytrauma patients, and it is associated with increased mortality and extended hospital length of stay. However, the specific prevalence of acute kidney injury after traumatic brain injury is less recognized. The present study aims to describe the occurrence rate, risk factors, timing, and association with outcome of acute kidney injury in a large cohort of traumatic brain injury patients.

Design: The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury is a multicenter, prospective observational, longitudinal, cohort study.

Setting: Sixty-five ICUs across Europe.

Patients: For the present study, we selected 4,509 traumatic brain injury patients with an ICU length of stay greater than 72 hours and with at least two serum creatinine values during the first 7 days of ICU stay.

Measurements and main results: We classified acute kidney injury in three stages according to the Kidney Disease Improving Global Outcome criteria: acute kidney injury stage 1 equals to serum creatinine × 1.5-1.9 times from baseline or an increase greater than or equal to 0.3 mg/dL in 48 hours; acute kidney injury stage 2 equals to serum creatinine × 2-2.9 times baseline; acute kidney injury stage 3 equals to serum creatinine × three times baseline or greater than or equal to 4 mg/dL or need for renal replacement therapy. Standard reporting techniques were used to report incidences. A multivariable Cox regression analysis was performed to model the cause-specific hazard of acute kidney injury and its association with the long-term outcome. We included a total of 1,262 patients. The occurrence rate of acute kidney injury during the first week was as follows: acute kidney injury stage 1 equals to 8% (n = 100), acute kidney injury stage 2 equals to 1% (n = 14), and acute kidney injury stage 3 equals to 3% (n = 36). Acute kidney injury occurred early after ICU admission, with a median of 2 days (interquartile range 1-4 d). Renal history (hazard ratio = 2.48; 95% CI, 1.39-4.43; p = 0.002), insulin-dependent diabetes (hazard ratio = 2.52; 95% CI, 1.22-5.197; p = 0.012), hypernatremia (hazard ratio = 1.88; 95% CI, 1.31-2.71; p = 0.001), and osmotic therapy administration (hazard ratio = 2.08; 95% CI, 1.45-2.99; p < 0.001) were significantly associated with the risk of developing acute kidney injury. Acute kidney injury was also associated with an increased ICU length of stay and with a higher probability of 6 months unfavorable Extended Glasgow Outcome Scale and mortality.

Conclusions: Acute kidney injury after traumatic brain injury is an early phenomenon, affecting about one in 10 patients. Its occurrence negatively impacts mortality and neurologic outcome at 6 months. Osmotic therapy use during ICU stay could be a modifiable risk factor.

Trial registration: ClinicalTrials.gov NCT02210221.

Conflict of interest statement

Dr. Meyfroidt’s institution received funding from Research Foundation, Flanders, KULeuven Research Grant (C2), and Codman; he received funding from other consulting and advisory boards. Dr. Citerio is Editor-in-Chief of Intensive Care Medicine, and he reports grants, personal fees as Speakers’ Bureau Member and Advisory Board Member from Integra and Neuroptics; personal fees from Nestle and UCB Pharma, all outside of the submitted work. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Copyright © 2020 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

References

    1. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 2005; 294:813–818
    1. Kellum JA. Acute kidney injury. Crit Care Med. 2008; 36:S141–S145
    1. Harrois A, Libert N, Duranteau J. Acute kidney injury in trauma patients. Curr Opin Crit Care. 2017; 23:447–456
    1. Harrois A, Soyer B, Gauss T, et al. Traumabase® Group: Prevalence and risk factors for acute kidney injury among trauma patients: A multicenter cohort study. Crit Care. 2018; 22:344
    1. Søvik S, Isachsen MS, Nordhuus KM, et al. Acute kidney injury in trauma patients admitted to the ICU: A systematic review and meta-analysis. Intensive Care Med. 2019; 45:407–419
    1. Nongnuch A, Panorchan K, Davenport A. Brain-kidney crosstalk. Crit Care. 2014; 18:225
    1. Maas AI, Menon DK, Steyerberg EW, et al. CENTER-TBI Participants and Investigators: Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): A prospective longitudinal observational study. Neurosurgery. 2015; 76:67–80
    1. Steyerberg EW, Wiegers E, Sewalt C, et al. CENTER-TBI Participants and Investigators: Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: A European prospective, multicentre, longitudinal, cohort study. Lancet Neurol. 2019; 18:923–934
    1. Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017; 80:6–15
    1. Kellum JA, Lameire N. KDIGO AKI Guideline Work Group: Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (part 1). Crit Care. 2013; 17:204
    1. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145:247–254
    1. Lingsma H, Andriessen TM, Haitsema I, et al. Prognosis in moderate and severe traumatic brain injury: External validation of the IMPACT models and the role of extracranial injuries. J Trauma Acute Care Surg. 2013; 74:639–646
    1. Kumar AB, Shi Y, Shotwell MS, et al. Hypernatremia is a significant risk factor for acute kidney injury after subarachnoid hemorrhage: A retrospective analysis. Neurocrit Care. 2015; 22:184–191
    1. Seeliger E, Ladwig M, Sargsyan L, et al. Proof of principle: Hydration by low-osmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats. Invest Radiol. 2012; 47:240–246
    1. Wu X, Zhang W, Ren H, et al. Diuretics associated acute kidney injury: Clinical and pathological analysis. Ren Fail. 2014; 36:1051–1055
    1. Karajala V, Mansour W, Kellum JA. Diuretics in acute kidney injury. Minerva Anestesiol. 2009; 75:251–257
    1. Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008; 148:284–294
    1. Shi J, Qian J, Li H, et al. Renal tubular epithelial cells injury induced by mannitol and its potential mechanism. Ren Fail. 2018; 40:85–91
    1. Yang B, Xu J, Xu F, et al. Intravascular administration of mannitol for acute kidney injury prevention: A systematic review and meta-analysis. PLoS One. 2014; 9:e85029
    1. Coritsidis G, Diamond N, Rahman A, et al. Hypertonic saline infusion in traumatic brain injury increases the incidence of pulmonary infection. J Clin Neurosci. 2015; 22:1332–1337
    1. Corry JJ, Varelas P, Abdelhak T, et al. Variable change in renal function by hypertonic saline. World J Crit Care Med. 2014; 3:61–67
    1. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012; 308:1566–1572
    1. Ergin B, Zuurbier CJ, Kapucu A, et al. Divergent effects of hypertonic fluid resuscitation on renal pathophysiological and structural parameters in rat model of lower body ischemia/reperfusion-induced sterile inflammation. Shock. 2018; 50:655–663
    1. Li N, Zhao WG, Zhang WF. Acute kidney injury in patients with severe traumatic brain injury: Implementation of the acute kidney injury network stage system. Neurocrit Care. 2011; 14:377–381
    1. Dutton RP, Stansbury LG, Leone S, et al. Trauma mortality in mature trauma systems: Are we doing better? an analysis of trauma mortality patterns, 1997-2008. J Trauma. 2010; 69:620–626
    1. Gomes E, Antunes R, Dias C, et al. Acute kidney injury in severe trauma assessed by RIFLE criteria: A common feature without implications on mortality? Scand J Trauma Resusc Emerg Med. 2010; 18:1
    1. Bagshaw SM, George C, Gibney RT, et al. A multi-center evaluation of early acute kidney injury in critically ill trauma patients. Ren Fail. 2008; 30:581–589
    1. Skinner DL, Hardcastle TC, Rodseth RN, et al. The incidence and outcomes of acute kidney injury amongst patients admitted to a level I trauma unit. Injury. 2014; 45:259–264
    1. Goyal K, Hazarika A, Khandelwal A, et al. Non- neurological complications after traumatic brain injury: A prospective observational study. Indian J Crit Care Med. 2018; 22:632–638
    1. Corral L, Javierre CF, Ventura JL, et al. Impact of non-neurological complications in severe traumatic brain injury outcome. Crit Care. 2012; 16:R44

Source: PubMed

3
Suscribir